Skip to main content
. 2020 Jul 11;7(5):3225–3230. doi: 10.1002/ehf2.12796

FIGURE 1.

FIGURE 1

Comparison of proportions of patients according to number of renin‐angiotensin‐aldosterone‐system inhibitors (RAASi) agents used between the first and last visit (P = 0.03)